Crossref Cited-by Linking logo

Collect. Czech. Chem. Commun. 2009, 74, 347-362
https://doi.org/10.1135/cccc2008072
Published online 2009-02-18 15:00:16

Identification, synthesis and structural determination of some impurities of candesartan cilexetil

Jaroslav Havlíčeka,*, Zuzana Mandelováa, Ruediger Weisemannb, Ivo Střeleca, Lukáš Plačeka and Stanislav Rádla

a Zentiva, U kabelovny 130, 102 37 Prague 10, Czech Republic
b Bruker BioSpin GmbH, Silberstreifen, 76287 Rheinstetten, Germany

Crossref Cited-by Linking

  • Dams Iwona, Ostaszewska Anna, Puchalska Maria, Chmiel Justyna, Cmoch Piotr, Bujak Iwona, Białońska Agata, Szczepek Wojciech: Synthesis and Physicochemical Characterization of the Process-Related Impurities of Olmesartan Medoxomil. Do 5-(Biphenyl-2-yl)-1-triphenylmethyltetrazole Intermediates in Sartan Syntheses Exist?. Molecules 2015, 20, 21346. <https://doi.org/10.3390/molecules201219762>
  • Rádl Stanislav, Černý Josef, Stach Jan, Holec Jan, Píša Ondřej, Gablíková Zuzana: Synthesis of Azilsartan and Its Selected Potential Impurities. J. Heterocyclic Chem. 2013, 50, 929. <https://doi.org/10.1002/jhet.1783>
  • Rádl Stanislav, Černý Josef, Stach Jan, Gablíková Zuzana: Improved Process for Azilsartan Medoxomil: A New Angiotensin Receptor Blocker. Org. Process Res. Dev. 2013, 17, 77. <https://doi.org/10.1021/op3002867>
  • Raman Bhanu, Sharma Brajesh A., Mahale Ganesh, Singh Dharmendra, Kumar Ashok: Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR. J  Pharm Biomed Anal 2011, 56, 256. <https://doi.org/10.1016/j.jpba.2011.05.024>